Overview

Serratus Anterior Plane Block With and Without Adjuvants in Video-assisted Thoracoscopy

Status:
Recruiting

Trial end date:
2022-10-01

Target enrollment:
0

Participant gender:
All

Summary

The purpose of this study is to determine whether the addition of the serratus anterior plane block (SAPB) alone (30 mL of 0.25% bupivacaine) or plus Magnesium (150 mg of magnesium sulfate) or plus Magnesium + Buprenorphine (300 mcg) as adjuvants can improve post-operative pain in patients undergoing video-assisted thoracoscopic surgery.

Phase:

N/A

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Wayne State University

Treatments:

Bupivacaine
Buprenorphine
Magnesium Sulfate
Pharmaceutical Solutions

Criteria

Inclusion Criteria:

- Patients undergoing video-assisted thoracoscopy

Exclusion Criteria:

- Patients with significant genetic or acquired clotting/bleeding disorders (hemophilia,
DIC, etc.)

- Patients with significant platelet dysfunction

- Infection at site for regional anesthesia

- Allergy to local anesthetics

- Sepsis